1 documents found
Information × Registration Number 0302U001034, 0100U002388 , R & D reports Title To evaluate the informativity and to develope the system of tumormarker's using to monitoring of radiotherapy's efficacy in the oncological patients. popup.stage_title Оцінити вплив променевої терапії на вміст ПСА у хворих на рак молочної і передміхурової залоз, рак легені залежно від гістотипу пухлини. Head Rozenfel'd L.G., Registration Date 16-01-2002 Organization Grigor'ev Institut for Medical Radiology popup.description2 Subject of investigation: patients with prostate cancer (45), patients with breast cancer (20). Objectives: To develop the criteria of oncomarker use (PSA, bombesin) for monitoring radiotherapy efficacy in breast, prostate and lung cancer. Меthods: clinical instrumental, radioimmune, immunoenzyme. Results: : PSA level in prostate cancer during radiotherapy was studied. PSA, Ca 15-3, lactopherone and Ca-125 amounts in breast cancer were established. For the first time, diagnostic significance of PSA marker for radiotherapy efficacy monitoring was evaluated. Fields of application: medicine, oncology research institutes, regional oncology hospitals, oncology and radiology centers. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
To evaluate the informativity and to develope the system of tumormarker's using to monitoring of radiotherapy's efficacy in the oncological patients.
Head: Rozenfel'd L.G.. To evaluate the informativity and to develope the system of tumormarker's using to monitoring of radiotherapy's efficacy in the oncological patients.. (popup.stage: Оцінити вплив променевої терапії на вміст ПСА у хворих на рак молочної і передміхурової залоз, рак легені залежно від гістотипу пухлини.). Grigor'ev Institut for Medical Radiology. № 0302U001034
1 documents found

Updated: 2026-03-20


Роздрукувати цю сторінку